SIGNIFICANTLY DIFFERENT IMMUNE MICROENVIRONMENT BETWEEN TRIPLE-NEGATIVE BREAST CANCER WITH AND WITHOUT NEOADJUVANT CHEMOTHERAPY THROUGH MULTIPLEX IMMUNOHISTOCHEMISTRY

被引：0
|
作者：
Lee, Miseon [1 ]
Lee, Hyun [2 ]
Gong, Gyungyub [3 ]
Lee, Hee Jin [3 ]
机构：
[1] Seoul St Marys Hosp, Coll Med, Seoul, South Korea
[2] NeogenTC Corp, Gyeonggi Do, Hanam Si, South Korea
[3] Univ Ulsan, Coll Med, Seoul, South Korea
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0963
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
963
引用
收藏
页码：A1004 / A1004
页数：1
相关论文
共 50 条
  • [31] Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer
    Hatzis, Christos
    Symmans, W. Fraser
    Zhang, Ya
    Gould, Rebekah E.
    Moulder, Stacy L.
    Hunt, Kelly K.
    Abu-Khalaf, Maysa
    Hofstatter, Erin W.
    Lannin, Donald
    Chagpar, Anees B.
    Pusztai, Lajos
    CLINICAL CANCER RESEARCH, 2016, 22 (01) : 26 - 33
  • [32] Factors associated with response to neoadjuvant chemotherapy and immune checkpoint inhibition in triple-negative breast cancer.
    Levee, Alexis
    Wong, Megan
    Flores, Sarah
    Ruel, Nora H.
    Lavasani, Sayeh Moazami
    Patel, Niki
    Sedrak, Mina S.
    Stewart, Daphne B.
    Waisman, James Ross
    Yuan, Yuan
    Mortimer, Joanne E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Single arm study of neoadjuvant chemotherapy without taxane for BRCAness cases in triple-negative breast cancer
    Ishikawa, Takashi
    Teraoka, Saeko
    Kaise, Hiroshi
    Yamada, Kimito
    Hosonaga, Man
    Ueda, Ai
    Kawai, Yoko
    Okazaki, Miki
    Oba, Mari S.
    Sato, Eiichi
    CANCER RESEARCH, 2016, 76
  • [34] IMMUNE RESPONSES DURING NEOADJUVANT CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER
    Ghallab, Ahmed
    EXCLI JOURNAL, 2020, 19 : 1295 - 1296
  • [35] Deconvolution of the triple-negative breast cancer microenvironment
    Saleh, Sadiq
    Gruosso, Tina
    Gigoux, Mathieu
    Bertos, Nicholas
    Omeroglu, Atilla
    Zuo, Dongmei
    Meterissian, Sarkis
    Hallett, Michael
    Park, Morag
    CANCER RESEARCH, 2016, 76
  • [36] Neoadjuvant Camrelizumab for Triple-Negative Breast Cancer
    Joensuu, Heikki
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [37] Spatial mapping of the immune microenvironment in primary triple-negative breast cancer (TNBC) and association with neoadjuvant therapy response
    Telli, M. L.
    Vinayak, S.
    Khododoust, M. S.
    Gruber, J. J.
    Ford, J. M.
    Sanchez, P.
    Banayan, N.
    Azimi, S.
    Tumeh, P. C.
    Newman, A. M.
    Alizadeh, A. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [38] Prognostic Value of Immunohistochemistry-based Subtyping Before and After Neoadjuvant Chemotherapy in Patients with Triple-negative Breast Cancer
    Wu, Long
    Chen, Minyan
    Lin, Yuxiang
    Zeng, Bangwei
    Guo, Wenhui
    Chen, Lili
    Li, Yan
    Yu, Liuwen
    Li, Jing
    Chen, Xiaobin
    Zhang, Wenzhe
    Li, Shengmei
    Cai, Weifeng
    Zhang, Kun
    Jin, Xuan
    Huang, Jianping
    Lin, Qili
    Yang, Yinghong
    Fu, Fangmeng
    Wang, Chuan
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (01) : 27 - 35
  • [39] Mitochondrial transplantation modulated tumor microenvironment in triple-negative breast cancer with chemotherapy
    Chang, Jui-Chih
    Chang, Huei-Shin
    Chen, Shou-Tung
    CANCER SCIENCE, 2025, 116 : 538 - 538
  • [40] Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    Jung, Yoon Yang
    Hyun, Chang Lim
    Jin, Min-Sun
    Park, In Ae
    Chung, Yul Ri
    Shim, Bobae
    Lee, Kyu Ho
    Ryu, Han Suk
    JOURNAL OF BREAST CANCER, 2016, 19 (03) : 261 - 267
12345